(Q48499164)

12 February 2018

title

Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre. (English)

1 reference

12 February 2018

0 references

0 references

M Zwerink

1

1 reference

12 February 2018

T P Zomer

2

1 reference

12 February 2018

B van Kooten

3

1 reference

12 February 2018

G Blaauw

4

1 reference

12 February 2018

T van Bemmel

5

1 reference

12 February 2018

B C van Hees

6

1 reference

12 February 2018

Y M Vermeeren

7

1 reference

12 February 2018

G W Landman

8

1 reference

12 February 2018

publication date

24 December 2017

1 reference

12 February 2018

Ticks and Tick-borne Diseases

published in

1 reference

12 February 2018

A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Lyme disease testing by large commercial laboratories in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

The Positive Predictive Value of Lyme Elisa for the Diagnosis of Lyme Disease in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Prospective study of serologic tests for lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

Depressive Symptoms in Patients Referred to a Tertiary Lyme Center: High Prevalence in Those Without Evidence of Lyme Borreliosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2017.12.014

10.1016/J.TTBDIS.2017.12.014

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

29422448

1 reference

12 February 2018